These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9188858)

  • 1. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1.
    Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H
    Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK.
    Murakami M; Ui M; Iba H
    Cell Growth Differ; 1999 May; 10(5):333-42. PubMed ID: 10359014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
    Hussain S; Kilbey A; Gillespie DA
    Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
    Catling AD; Wyke JA; Frame MC
    Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
    Kilbey A; Black EJ; Unlu M; Gillespie DA
    Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
    Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
    Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
    J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
    Ramos-Nino ME; Timblin CR; Mossman BT
    Cancer Res; 2002 Nov; 62(21):6065-9. PubMed ID: 12414630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AP-1 and ATF-2 are constitutively activated via the JNK pathway in Theileria parva-transformed T-cells.
    Botteron C; Dobbelaere D
    Biochem Biophys Res Commun; 1998 May; 246(2):418-21. PubMed ID: 9610375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silica-induced activation of c-Jun-NH2-terminal amino kinases, protracted expression of the activator protein-1 proto-oncogene, fra-1, and S-phase alterations are mediated via oxidative stress.
    Shukla A; Timblin CR; Hubbard AK; Bravman J; Mossman BT
    Cancer Res; 2001 Mar; 61(5):1791-5. PubMed ID: 11280724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity.
    Gruda MC; Kovary K; Metz R; Bravo R
    Oncogene; 1994 Sep; 9(9):2537-47. PubMed ID: 8058317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
    Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
    Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
    Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters.
    Rutberg SE; Saez E; Lo S; Jang SI; Markova N; Spiegelman BM; Yuspa SH
    Oncogene; 1997 Sep; 15(11):1337-46. PubMed ID: 9315102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
    Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
    Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins.
    Gopalbhai K; Meloche S
    J Cell Physiol; 1998 Jan; 174(1):35-47. PubMed ID: 9397154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.